Baohuoside V

Details

Top
Internal ID 10a32618-218d-4ae3-a7e3-43cc80303469
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid O-glycosides > Flavonoid-7-O-glycosides
IUPAC Name 3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)OC5C(C(C(C(O5)CO)O)O)O)O)C6=CC=C(C=C6)O)C)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)C6=CC=C(C=C6)O)C)O)O)O)O)O
InChI InChI=1S/C38H48O19/c1-13(2)5-10-18-20(53-37-31(50)28(47)25(44)21(12-39)54-37)11-19(41)22-26(45)34(32(55-33(18)22)16-6-8-17(40)9-7-16)56-38-35(29(48)24(43)15(4)52-38)57-36-30(49)27(46)23(42)14(3)51-36/h5-9,11,14-15,21,23-25,27-31,35-44,46-50H,10,12H2,1-4H3/t14-,15-,21+,23-,24-,25+,27+,28-,29+,30+,31+,35+,36-,37+,38-/m0/s1
InChI Key ABEPLDYBWOKMCT-KUBBBFTRSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C38H48O19
Molecular Weight 808.80 g/mol
Exact Mass 808.27897930 g/mol
Topological Polar Surface Area (TPSA) 304.00 Ų
XlogP 0.20
Atomic LogP (AlogP) -1.38
H-Bond Acceptor 19
H-Bond Donor 11
Rotatable Bonds 10

Synonyms

Top
118544-18-6
3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
BaohuosideV
Diphylloside B; Baohuoside V
HY-N2280
AKOS037515074
CS-0019609

2D Structure

Top
2D Structure of Baohuoside V

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8664 86.64%
Caco-2 - 0.9313 93.13%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.8000 80.00%
Subcellular localzation Mitochondria 0.7171 71.71%
OATP2B1 inhibitior - 0.5776 57.76%
OATP1B1 inhibitior + 0.8879 88.79%
OATP1B3 inhibitior + 0.9366 93.66%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9317 93.17%
P-glycoprotein inhibitior + 0.6468 64.68%
P-glycoprotein substrate + 0.5478 54.78%
CYP3A4 substrate + 0.6690 66.90%
CYP2C9 substrate - 0.6532 65.32%
CYP2D6 substrate - 0.8528 85.28%
CYP3A4 inhibition - 0.9436 94.36%
CYP2C9 inhibition - 0.7241 72.41%
CYP2C19 inhibition - 0.6819 68.19%
CYP2D6 inhibition - 0.8386 83.86%
CYP1A2 inhibition - 0.6373 63.73%
CYP2C8 inhibition + 0.7404 74.04%
CYP inhibitory promiscuity + 0.5000 50.00%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.7420 74.20%
Eye corrosion - 0.9906 99.06%
Eye irritation - 0.9073 90.73%
Skin irritation - 0.7969 79.69%
Skin corrosion - 0.9499 94.99%
Ames mutagenesis - 0.5028 50.28%
Human Ether-a-go-go-Related Gene inhibition + 0.7378 73.78%
Micronuclear - 0.5367 53.67%
Hepatotoxicity - 0.6500 65.00%
skin sensitisation - 0.8659 86.59%
Respiratory toxicity + 0.5889 58.89%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.7218 72.18%
Acute Oral Toxicity (c) III 0.6098 60.98%
Estrogen receptor binding + 0.8013 80.13%
Androgen receptor binding + 0.6711 67.11%
Thyroid receptor binding + 0.5266 52.66%
Glucocorticoid receptor binding + 0.5921 59.21%
Aromatase binding + 0.5757 57.57%
PPAR gamma + 0.7259 72.59%
Honey bee toxicity - 0.6462 64.62%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.6000 60.00%
Fish aquatic toxicity + 0.9827 98.27%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.72% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 97.27% 89.00%
CHEMBL2581 P07339 Cathepsin D 97.23% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 96.13% 91.49%
CHEMBL3401 O75469 Pregnane X receptor 95.24% 94.73%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 94.88% 94.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 94.22% 86.33%
CHEMBL3060 Q9Y345 Glycine transporter 2 93.44% 99.17%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.60% 94.45%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 88.12% 93.10%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.58% 95.56%
CHEMBL1937 Q92769 Histone deacetylase 2 84.99% 94.75%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 84.98% 99.15%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 84.30% 95.78%
CHEMBL3194 P02766 Transthyretin 83.66% 90.71%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 83.14% 95.64%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 82.38% 96.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.37% 85.14%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 81.33% 86.92%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 80.81% 83.57%

Cross-Links

Top
PubChem 25087702
NPASS NPC137966
LOTUS LTS0146000
wikiData Q104908570